Beximco Pharmaceuticals Limited (BXP.L)

GBp 36.5

(0.0%)

Annual Balance Sheets

(In BDT)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 69.15 Billion 66.14 Billion 52.24 Billion 50.11 Billion 49.21 Billion 43.73 Billion
Total Current Assets 20.87 Billion 18.41 Billion 13.77 Billion 13.04 Billion 13.26 Billion 11.34 Billion
Cash And Short Term Investments 1.13 Billion 1.16 Billion 675.46 Million 635.01 Million 933.85 Million 733.13 Million
Cash and Cash Equivalents 1.13 Billion 1.16 Billion 675.46 Million 635.01 Million 610.49 Million 393.73 Million
Short Term Investments 166.25 Million 108.07 Million 112.82 Million 70.79 Million 323.36 Million 339.39 Million
Net Receivables 3.36 Billion -11.12 Billion 4.5 Billion 3.08 Billion 3.24 Billion 2.76 Billion
Inventory 12.95 Billion 11.12 Billion 7.8 Billion 6.72 Billion 6.65 Billion 5.72 Billion
Other Current Assets 2.73 Billion 17.25 Billion 788.81 Million 751.15 Million 1.78 Billion 4.88 Billion
Total Non-Current Assets 48.28 Billion 47.72 Billion 38.47 Billion 37.06 Billion 35.94 Billion 32.39 Billion
Net PPE 42.8 Billion 42.37 Billion 36.53 Billion 35.24 Billion 34.05 Billion 30.52 Billion
Good Will And Intangible Assets 5.39 Billion 5.23 Billion 1.92 Billion 1.82 Billion 1.88 Billion 1.82 Billion
Good Will 674.57 Million 674.57 Million 546.69 Million 546.69 Million 546.69 Million 546.69 Million
Intangible Assets 4.72 Billion 4.56 Billion 1.38 Billion 1.27 Billion 1.33 Billion 1.28 Billion
Long-Term Investments 20.97 Million 23.35 Million 16.59 Million 3.75 Million -318.03 Million -302.88 Million
Tax Assets 56.51 Million 88.64 Million -16.59 Million -3.75 Million 323.36 Million 339.39 Million
Other Non Current Assets - - 16.59 Million 6.43 Million 6.32 Million 6.09 Million
Other Assets - - - - - -
Total Liabilities 21.53 Billion 21.51 Billion 14.88 Billion 17.32 Billion 19.34 Billion 16.38 Billion
Total Current Liabilities 13.26 Billion 12.73 Billion 9.34 Billion 11.35 Billion 12.74 Billion 9.01 Billion
Account Payables 3.53 Billion 2.46 Billion 1.96 Billion 1.46 Billion 1.09 Billion 991.71 Million
Tax Payables 454.08 Million 99.44 Million 222.5 Million 285.88 Million 167.29 Million 433.41 Million
Short Term Debt 8.06 Billion 8.91 Billion 6.42 Billion 8.85 Billion 10.88 Billion 7.16 Billion
Deferred Revenue - - 368.43 Million - - 433.41 Million
Other Current Liabilities 1.67 Billion 1.35 Billion 591.6 Million 1.04 Billion 764.85 Million 423.24 Million
Total Non Current Liabilities 8.27 Billion 8.77 Billion 5.53 Billion 5.96 Billion 6.6 Billion 7.36 Billion
Long-Term Debt 2.55 Billion 3.45 Billion 1.2 Billion 1.65 Billion 2.59 Billion 4.01 Billion
Deferred Revenue Non Current - - 2.1 Billion - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 3.17 Billion 2.78 Billion 234.02 Million 2.14 Billion 1.86 Billion 1.32 Billion
Other Liabilities - - - - - -
Total Equity 47.61 Billion 44.63 Billion 37.36 Billion 32.79 Billion 29.86 Billion 27.35 Billion
Stock Holders Equity 43.68 Billion 40.6 Billion 37.03 Billion 32.49 Billion 29.58 Billion 27.08 Billion
Common Stock 4.46 Billion 4.46 Billion 4.46 Billion 4.05 Billion 4.05 Billion 4.05 Billion
Retained Earnings 30.8 Billion 27.74 Billion 24.17 Billion 20.05 Billion 17.14 Billion 14.6 Billion
Accumulated other comprehensive income 1.45 Billion 1.43 Billion 1.43 Billion 1.42 Billion 1.42 Billion -8.55 Billion
Common Stock Equity 43.68 Billion 40.6 Billion 37.03 Billion 32.49 Billion 29.58 Billion 27.08 Billion
Capital Lease Obligation 539.63 Million 617.34 Million 347.99 Million 316.97 Million 413.14 Million 481.6 Million
Total Investments 20.97 Million 23.35 Million 16.59 Million 3.75 Million 5.32 Million 36.5 Million
Total Debt 10.61 Billion 12.37 Billion 7.63 Billion 10.5 Billion 13.48 Billion 11.18 Billion
Net Debt 9.47 Billion 11.2 Billion 6.95 Billion 9.86 Billion 12.87 Billion 10.79 Billion

Balance Sheet Charts